Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he meant Ozempic or Wegovy.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

News Reporter Eric Stonestreet, the actor known for playing Cam on Modern Family, is teaming up with his mother to sell the weight-loss drug Mounjaro ... giant Eli Lilly. Like better-known ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...

Picture: Larry Cummins. Thu, 01 May, 2025 - 20:31 Eli Lilly posted better-than-expected quarterly results, although sales of its popular weight-loss drug Zepbound came in slightly below estimates.

US wellness giant WeightWatchers, which was reportedly gearing up to file for bankruptcy, announced a partnership with Eli Lilly on Tuesday to provide easier access to Lilly’s weight loss drug ...

Eli Lilly said the revision reflects a $1. ... That's up a whopping 113% from the same period a year ago. The company's weight loss drug Zepbound also beat estimates, booking $2.31 billion in ...